Studies on the transformation of nitrosugars into branched chain iminosugars. Part II: Synthesis of (3R,4R,5R,6S)-2,2-bis(hydroxymethyl)azepane-3,4,5,6-tetraol

Tetrahedron Asymmetry

Volumn 19, Issue 21, 2008, Pages 2443-2446

  Otero, José M ^a   Estévez, Amalia M ^a   Soengas, Raquel G ^a   Estévez, Juan C ^a   Nash, Robert J ^b   Fleet, George W J ^c   Estévez, Ramón J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Summit (Wales) Limited   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,6 DIDEOXY 1,6 HEPTITOL; 2,2 BIS(HYDROXYMETHYL)AZEPANE 3,4,5,6 TETRAOL; CARBOHYDRATE DERIVATIVE; FORMALDEHYDE; GLYCOSIDASE; GLYCOSIDASE INHIBITOR; HYDROXYL GROUP; IMINOSUGAR; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; MELTING POINT; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

EID: 57049161891     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2008.10.027     Document Type: Article

References (30)

1. Asano N., Nash R.J., Molyneux R.J., and Fleet G.W.J. Tetrahedron: Asymmetry 11 (2000) 1645
2. Lillelund V.H., Jensen H.H., Liang X., and Bols M. Chem. Rev. 102 (2002) 515
3. Compain P., and Martin O.R. Iminosugars: from synthesis to therapeutic applications (2007), John Wiley, Chichester
4. Butters T., Dwek R.A., and Platt F.M. Curr. Top Med. Chem. 3 (2003) 561
5. Mitrakou A., Tountas N., Raptis A.E., Bauer R.J., Schulz H., and Raptis S.A. Diabetic Med. 15 (1998) 657
6. Zitzmann N., Metha A.S., Carrouée S., Butters T.D., Platt F.M., McCauley J., Blumberg B.S., Dwek R.A., and Block T.M. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 11878
7. Asano N. J. Enzyme Inhib. 15 (2000) 215
8. Wu S.-F., Li C.-J., Liao C.-L., Dwek R.A., Zitzmann N., and Lin Y.-L. J. Virol. 76 (2002) 3596
9. Greimel P., Spreitz J., Stütz A.E., and Wrodnigg T.M. Curr. Top. Med. Chem. 3 (2003) 513
10. Jacob G.S. Curr. Opin. Struct. Biol. 5 (1995) 605
11. Inoue S., Tsuruoka T., and Niida T. J. Antibiot. 19 (1966) 288
12. Asano N., Oseki K., Kiuz H., and Matsui K. J. Med. Chem. 37 (1994) 3701
13. Stütz A. Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond (1999), Wiley-VCH, Weinheim
14. Paulsen H., and Todt K. Chem. Ber. 100 (1967) 512
15. Andreana P.R., Sanders T., Janczuk A., Warrick J.I., and Wang P.G. Tetrahedron Lett. 43 (2002) 6525
16. Joseph C.C., Regeling H., Zwanenburg B., and Chittenden G.J.F. Tetrahedron 58 (2002) 6907
17. Fuentes J., Gash C., Olano D., Pradera M.A., Repetto P., and Sayago F.J. Tetrahedron: Asymmetry 13 (2002) 1743
18. Dhavale D.D., Chaudhari V.D., and Tilekar J.N. Tetrahedron 44 (2003) 7321 and references cited therein
19. Li H., Blériot Y., Chantereau C., Mallet J.M., Sollogoub M., Zhang Y., García E.R., Vogel P., Barbero J.J., and Sinaÿ P. Org. Biomol. Chem. 2 (2004) 1492
20. Martínez-Mayorga K., Medina-Franco J.L., Mari S., Cañada F.J., Rodríguez-García E., Vogel P., Li H., Blériot Y., Sinaÿ P., and Barbero J.J. Eur. J. Org. Chem. 20 (2004) 4119
21. Johnson H.A., and Thomas N.R. Bioorg. Med. Chem. Lett. 12 (2002) 237
22. Otero J.M., Fernández F., Estévez J.C., and Estévez R.J. Tetrahedron: Asymmetry 16 (2005) 4045
23. Otero J.M., Barcia J.C., Estévez J.C., and Estévez R.J. Tetrahedron: Asymmetry 16 (2005) 11
24. Soengas R.G., Pampín M.B., Estévez J.C., and Estévez R.J. Tetrahedron: Asymmetry 15 (2005) 211
25. Soengas R.G., Estévez J.C., and Estévez R.J. Tetrahedron: Asymmetry 14 (2003) 3955
26. Soengas R.G., Estévez J.C., and Estévez R.J. Org. Lett. 5 (2003) 4457
27. Soengas R.G., Estévez J.C., Estévez R.J., and Maestro M.A. Tetrahedron: Asymmetry 14 (2003) 1653
28. Soengas R.G., Estévez J.C., and Estévez R.J. Org. Lett. 5 (2003) 1423
29. Otero J.M., Soengas R.G., Estévez J.C., Estévez R.J., Watking D.J., Evinson E.L., Nash R.J., and Fleet G.W.J. Org. Lett. 9 (2007) 623
30. Fleet G.W.J., Carpenter N.M., Petursson S., and Ramsden N.G. Tetrahedron Lett. 31 (1990) 409